Various alphabetized medical records

Life Sciences Commercial Disputes

New product introductions in the life sciences sector are frequently complex, costly, and time-consuming undertakings, and collaborations between companies are common. Disputes may arise at all stages of development and commercialization. Our expertise helps clients navigate litigated and arbitrated disputes involving drug development and commercialization and analyze relevant commercial factors (size of the opportunity, therapeutic area, business risks, etc.). CRA has provided expert reports and testimony evaluating development and commercialization efforts and assessing damages associated with alleged contractual breaches and other commercial issues.

Our focus areas


  • 01
    Alleged breach of license agreement
    CRA was retained by the claimant in an arbitration regarding the breach of a license agreement relating to pharmaceutical manufacturing technology. Dr. Sean...
    View engagement
  • 02
    Practices and procedures of nonprofit technology transfer offices
    CRA was retained by the United States government to provide opinions on the typical practices and procedures of nonprofit technology transfer offices in a...
    View engagement
  • 03
    CRA analyses aid settlement negotiation in breach of contract dispute
    CRA was retained by the claimant in a JAMS arbitration regarding a breach of contract dispute in connection with an oncology product. CRA’s team assisted...
    View engagement

Subscribe to recieve our latest Insights.